Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Androgen aggravates aortic aneurysms via suppression of PD-1 in mice
Xufang Mu, … , Ming C. Gong, Zhenheng Guo
Xufang Mu, … , Ming C. Gong, Zhenheng Guo
Published June 20, 2024
Citation Information: J Clin Invest. 2024;134(15):e169085. https://doi.org/10.1172/JCI169085.
View: Text | PDF
Research Article Inflammation Vascular biology Article has an altmetric score of 20

Androgen aggravates aortic aneurysms via suppression of PD-1 in mice

  • Text
  • PDF
Abstract

Androgen has long been recognized for its pivotal role in the sexual dimorphism of cardiovascular diseases, including aortic aneurysms (AAs), a devastating vascular disease with a higher prevalence and fatality rate in men than in women. However, the mechanism by which androgen mediates AAs is largely unknown. Here, we found that male, not female, mice developed AAs when exposed to aldosterone and high salt (Aldo-salt). We revealed that androgen and androgen receptors (ARs) were crucial for this sexually dimorphic response to Aldo-salt. We identified programmed cell death protein 1 (PD-1), an immune checkpoint, as a key link between androgen and AAs. Furthermore, we demonstrated that administration of anti–PD-1 Ab and adoptive PD-1–deficient T cell transfer reinstated Aldo-salt–induced AAs in orchiectomized mice and that genetic deletion of PD-1 exacerbated AAs induced by a high-fat diet and angiotensin II (Ang II) in nonorchiectomized mice. Mechanistically, we discovered that the AR bound to the PD-1 promoter to suppress the expression of PD-1 in the spleen. Thus, our study unveils a mechanism by which androgen aggravates AAs by suppressing PD-1 expression in T cells. Moreover, our study suggests that some patients with cancer might benefit from screenings for AAs during immune checkpoint therapy.

Authors

Xufang Mu, Shu Liu, Zhuoran Wang, Kai Jiang, Tim McClintock, Arnold J. Stromberg, Alejandro V. Tezanos, Eugene S. Lee, John A. Curci, Ming C. Gong, Zhenheng Guo

×

Figure 12

Genetic deletion of PD-1 exacerbates HFD- and Ang II–induced aortopathy.

Options: View larger image (or click on image) Download as PowerPoint
Genetic deletion of PD-1 exacerbates HFD- and Ang II–induced aortopathy....
(A and B) Maximal internal diameters of the SupAo and aortic root in 2-month-old male PD-1–KO and WT C57BL/6J mice with 8-week HFD feeding and 4-week Ang II infusion (n = 15/group). *P < 0.05, **P < 0.01, and ****P < 0.0001, vs. WT at 6, 7, and 8 weeks, respectively. (C) Aortic weight/BW ratio (n = 14/group). (D) Maximal external diameters of the AscAo, ArchAo, DesAo, and SupAo (n = 14/group). (E) Incidence of total AAs, AAAs, TAAs, and aortic ruptures. (F and G) Representative Verhoeff-Van Gieson elastin staining of abdominal aortas and quantitative data. Arrow indicates elastic breakage (n = 6–7/group). Scale bars: 20 μm and 100 μm (enlarged insets). (H) Representative immunostaining of T cells, B cells, macrophages, and neutrophils in the abdominal aorta (n = 3). (I) MAP was measured by tail cuff 1 week before (basal) and 3 weeks after HFD and Ang II administration (n = 14–15/group). Scale bar: 200 μm. (J) Correlation analysis of the internal diameter of the SupAo and MAP in PD-1–KO and WT mice 3 weeks after HFD and Ang II administration (n = 28/group). (K) MAP with (+) and without (–) AAs (n =2–12/group). Data are expressed as the mean ± SEM and were analyzed by 2-way ANOVA with multiple-comparison test (A, B, I, and K), 2-tailed, unpaired t test (C, D, and G), 2-sided χ2 test (E), and simple linear regression analysis (J). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Posted by 5 X users
On 1 Facebook pages
8 readers on Mendeley
See more details